The Changes include the following updates:
Group 4E Nicotinic acetylcholine receptor (nAChR) competitive modulators – New Active: Fenmezoditiaz
Group 23: Inhibitors of acetyl-CoA carboxylase – New Active: Spidoxamat.
Group 35 RNA Interference mediated target suppressors New Group and Active: Ledprona
Group UNF Fungal agents of unknown or uncertain MoA New Fungal Agent added: Akanthomyces muscarius Ve6